| Advancements in prophylactic and therapeutic nanovaccines P Bhardwaj, E Bhatia, S Sharma, N Ahamad, R Banerjee Acta Biomaterialia 108, 1-21, 2020 | 144 | 2020 |
| Immunomodulatory nanosystems for treating inflammatory diseases N Ahamad, A Kar, S Mehta, M Dewani, V Ravichandran, P Bhardwaj, ... Biomaterials 274, 120875, 2021 | 66 | 2021 |
| Multifunctional core–shell glyconanoparticles for galectin-3-targeted, trigger-responsive combination chemotherapy B Balakrishnan, S Subramanian, MB Mallia, K Repaka, S Kaur, ... Biomacromolecules 21 (7), 2645-2660, 2020 | 27 | 2020 |
| Loco-regional radiosensitizing nanoparticles-in-gel augments head and neck cancer chemoradiotherapy P Bhardwaj, V Gota, K Vishwakarma, V Pai, P Chaudhari, B Mohanty, ... Journal of Controlled Release 343, 288-302, 2022 | 15 | 2022 |
| Ultrasound augments on-demand breast tumor radiosensitization and apoptosis through a tri-responsive combinatorial delivery theranostic platform P Bhardwaj, JS Goda, V Pai, P Chaudhari, B Mohanty, T Pai, ... Nanoscale 13 (40), 17077-17092, 2021 | 11 | 2021 |
| Clinical toxicity of nanomedicines N Ahamad, P Bhardwaj, E Bhatia, R Banerjee Nano Medicine and Nano Safety: Recent Trends and Clinical Evidences, 533-560, 2020 | 10 | 2020 |
| Paper based Point of Care Diagnostics for Cancer Biomarkers P Bhardwaj, B Arora, S Saxena, S Singh, P Palkar, JS Goda, R Banerjee Sensors & Diagnostics, 2024 | 7 | 2024 |
| Stimulus‐Responsive Nanoparticles for Therapeutic Stabilization of Atherosclerosis S Mehta, N Ahamad, M Dewani, P Bhardwaj, R Banerjee Nanoengineering of Biomaterials, 181-215, 2022 | 2 | 2022 |
| O6-Guanine Targeting Novel DNA Cross-Linker and ATR Inhibitor Combination for MGMT-Silenced IDH1/2 Mutant Acute Myeloid Leukemia P Bhardwaj, R Sundaram, S Friedman, A Baassiri, M Matthews, ... Blood 144, 6130, 2024 | | 2024 |
| Abstract A081 Biomarker-driven targeting of NAD metabolism in rhabdomyosarcoma JC Vasquez, P Bhardwaj, S Zhao, K Noronha, K Lucas, R Sundaram, ... Cancer Research 84 (17_Supplement), A081-A081, 2024 | | 2024 |
| NAPRTsilencing in rhabdomyosarcoma confers therapeutic vulnerabilities to NAD+depletion SJ Zhao, KJ Noronha, P Bhardwaj, KN Lucas, RK Sundaram, CD Heer, ... Cancer Research 84 (6_Supplement), 2866-2866, 2024 | | 2024 |
| Biomarker-targeted alkylator and DNA damage repair inhibitor combination for refractory and relapsed acute myeloid leukemia (AML) P Bhardwaj, R Sundaram, A Baassiri, M Matthews, J VanOudenhove, ... Cancer Research 84 (6_Supplement), 7123-7123, 2024 | | 2024 |
| Augmentation of Radiotherapy Using a Novel Loco-regional Hydrogel Based Radiosensitizer Delivery Platform for Head and Neck Squamous Cell Carcinoma P Bhardwaj, J Goda, V Gota, R Banerjee International Journal of Radiation Oncology, Biology, Physics 108 (3), S58, 2020 | | 2020 |